-
Analyst: Buy KushCo Holdings On Vaping Weakness
Wednesday, October 9, 2019 - 12:21pm | 442Read More...KushCo Holdings Inc (OTC: KSHB) stock has lost 72.21% year-to-date. With the company being an important player in the vaping industry, its shares have been hit hard in the last 30 days, with over 1,000 Americans falling ill from a lung disease tied to black market THC vapes. Nevertheless,...
-
Take Profits In Molina Health; Stifel Downgrades To Sell
Wednesday, May 31, 2017 - 10:25am | 293Read More...Stifel downgraded Molina Healthcare, Inc. (NYSE: MOH) to Sell as research analysts Thomas Carroll and Mark Kelly moved their price target to $60. Key Takeaways Carroll and Kelly do not believe “new management can successfully expand margins in the near-to-medium-term, grow revenues from a...
-
One Thing You Should Note About Molina's Q1 Earnings Per Share Figure
Thursday, May 4, 2017 - 9:37am | 392Read More...Molina Healthcare, Inc. (NYSE: MOH) announced first-quarter results Tuesday following an earlier announcement concerning the ouster of its CEO and chief financial officer, both sons of the healthcare company's founder. The 'Adjusted, Adjusted' Earnings Stifel in a note looked at what it termed as...
-
Analysts Hike UnitedHealth Estimates, Had Good Vibes At Investor Day
Wednesday, December 2, 2015 - 10:15am | 492Read More...Shares of UnitedHealth Group Inc (NYSE: UNH) have been volatile in 2015 and are up 15 percent year-to-date. Analysts tat BMO Capital Markets, Susquehenna and Stifel maintained their Outperform, Positive and Buy ratings on the company. Apart from the problems related to its ACA exchange...
-
UPDATE: Stifel Upgrades Humana
Friday, June 6, 2014 - 9:25am | 174Read More...In a note released Friday morning, Stifel analyst Thomas Carroll upgraded shares of Humana (NYSE: HUM) from Hold to Buy and set a $155 price target. "We believe investors should own shares ahead of 2Q14 earnings, add more if weak Health Insurance Exchange (HIE) results pressure shares, and manage...
-
UPDATE: Stifel Nicolaus Downgrades Humana on Best Case Scenario
Thursday, August 1, 2013 - 10:27am | 182Read More...In a report published Thursday, Stifel Nicolaus analyst Thomas Carroll downgraded Humana (NYSE: HUM) from Buy to Hold, and removed the $90.00 price target. In the report, Stifel Nicolaus noted, “Humana has not merely managed its challenges this year - it has achieved what we would call best...
-
UPDATE: Stifel Nicolaus Initiates Aetna at Buy on Good Market Position
Tuesday, July 23, 2013 - 8:45am | 126Read More...In a report published Tuesday, Stifel Nicolaus analyst Thomas Carroll initiated coverage on Aetna (NYSE: AET) with a Buy rating and $80.00 price target. In the report, Stifel Nicolaus noted, “In our view, Aetna has effectively positioned itself to become a more prominent managed care...
